200 related articles for article (PubMed ID: 32167686)
1. [The role of Epstein-Barr viral infection and hepatitis B and C in liver pathology.].
Solomay TV; Semenenko TA; Ivanova MY
Vopr Virusol; 2019; 64(5):215-220. PubMed ID: 32167686
[TBL] [Abstract][Full Text] [Related]
2. [Viral hepatitis B, C and infectious mononucleosis: epidemiological similarities and differences.].
Solomay TV; Semenenko TA
Vopr Virusol; 2020; 65(1):27-34. PubMed ID: 32496718
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
[TBL] [Abstract][Full Text] [Related]
4. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?
Bertoletti A; Maini MK
Curr Opin Microbiol; 2000 Aug; 3(4):387-92. PubMed ID: 10972499
[TBL] [Abstract][Full Text] [Related]
5. Acute Hepatitis E Virus infection with coincident reactivation of Epstein-Barr virus infection in an immunosuppressed patient with rheumatoid arthritis: a case report.
Schultze D; Mani B; Dollenmaier G; Sahli R; Zbinden A; Krayenbühl PA
BMC Infect Dis; 2015 Oct; 15():474. PubMed ID: 26511098
[TBL] [Abstract][Full Text] [Related]
6. Exploitation of host clock gene machinery by hepatitis viruses B and C.
Vinciguerra M; Mazzoccoli G; Piccoli C; Tataranni T; Andriulli A; Pazienza V
World J Gastroenterol; 2013 Dec; 19(47):8902-9. PubMed ID: 24379614
[TBL] [Abstract][Full Text] [Related]
7. Severe hepatitis caused by Epstein-Barr virus without infection of hepatocytes.
Kimura H; Nagasaka T; Hoshino Y; Hayashi N; Tanaka N; Xu JL; Kuzushima K; Morishima T
Hum Pathol; 2001 Jul; 32(7):757-62. PubMed ID: 11486177
[TBL] [Abstract][Full Text] [Related]
8. Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection.
Cheng X; Uchida T; Xia Y; Umarova R; Liu CJ; Chen PJ; Gaggar A; Suri V; Mücke MM; Vermehren J; Zeuzem S; Teraoka Y; Osawa M; Aikata H; Tsuji K; Mori N; Hige S; Karino Y; Imamura M; Chayama K; Liang TJ
J Clin Invest; 2020 Jun; 130(6):3205-3220. PubMed ID: 32163375
[TBL] [Abstract][Full Text] [Related]
9. A look behind closed doors: interaction of persistent viruses with dendritic cells.
Lambotin M; Raghuraman S; Stoll-Keller F; Baumert TF; Barth H
Nat Rev Microbiol; 2010 May; 8(5):350-60. PubMed ID: 20372157
[TBL] [Abstract][Full Text] [Related]
10. Viral-Associated GN: Hepatitis B and Other Viral Infections.
Kupin WL
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1529-1533. PubMed ID: 27797900
[TBL] [Abstract][Full Text] [Related]
11. Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection.
Piriou E; van Dort K; Otto S; van Oers MH; van Baarle D
Clin Infect Dis; 2008 Jan; 46(2):313-6. PubMed ID: 18171268
[TBL] [Abstract][Full Text] [Related]
12. Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells.
Zaghloul H; El-Sherbiny W
Immunol Invest; 2010 Jan; 39(3):284-91. PubMed ID: 20380524
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
[TBL] [Abstract][Full Text] [Related]
14. Safety Profile of Secukinumab in Treatment of Patients with Psoriasis and Concurrent Hepatitis B or C: A Multicentric Prospective Cohort Study.
Chiu HY; Hui RC; Huang YH; Huang RY; Chen KL; Tsai YC; Lai PJ; Wang TS; Tsai TF
Acta Derm Venereol; 2018 Oct; 98(9):829-834. PubMed ID: 29972221
[TBL] [Abstract][Full Text] [Related]
15. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
16. Virus-induced immune dysregulation as a triggering factor for the development of drug rashes and autoimmune diseases: with emphasis on EB virus, human herpesvirus 6 and hepatitis C virus.
Mizukawa Y; Shiohara T
J Dermatol Sci; 2000 Apr; 22(3):169-80. PubMed ID: 10698154
[TBL] [Abstract][Full Text] [Related]
17. Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis.
Selmi C; Ceribelli A; Vierling JM
Semin Immunopathol; 2013 Jan; 35(1):1-5. PubMed ID: 23250654
[No Abstract] [Full Text] [Related]
18. Epstein-Barr virus associated acute hepatitis with cross-reacting antibodies to other herpes viruses in immunocompetent patients: report of two cases.
Gupta E; Bhatia V; Choudhary A; Rastogi A; Gupta NL
J Med Virol; 2013 Mar; 85(3):519-23. PubMed ID: 23297155
[TBL] [Abstract][Full Text] [Related]
19. Animal model for study of human hepatitis viruses.
Chayama K; Hayes CN; Hiraga N; Abe H; Tsuge M; Imamura M
J Gastroenterol Hepatol; 2011 Jan; 26(1):13-8. PubMed ID: 21175788
[TBL] [Abstract][Full Text] [Related]
20. Immunology of hepatitis B and hepatitis C virus infections.
Boonstra A; Woltman AM; Janssen HL
Best Pract Res Clin Gastroenterol; 2008; 22(6):1049-61. PubMed ID: 19187866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
